Results 211 to 220 of about 55,450 (260)

Viral Hepatitis Vaccines

2011
HAV and HBV are prevalent worldwide, cause significant morbidity and mortality, and are vaccine-preventable.
Melissa L. Diamantis, Stephen K. Tyring
openaire   +1 more source

Viral hepatitis: Global goals for vaccination

Journal of Clinical Virology, 2012
In countries where hepatitis A is highly endemic, exposure to hepatitis A virus (HAV) is almost universal before the age of 10 years, and large-scale immunization efforts are not required. In contrast, in areas of intermediate endemicity or in transition from high to intermediate endemicity, where transmission occurs primarily from person to person in ...
openaire   +2 more sources

Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection

Vaccine, 1997
Patients on hemodialysis therapy are at a relatively high risk of exposure to hepatitis B virus (HBV) infection. The prevalence of hepatitis C virus (HCV) infection is even higher and was reported as 33.2% in Taiwan. Although the efficacy of hepatitis B vaccine was well documented, the vaccination schedule in hemodialysis patients is not clearly ...
C H, Cheng, C C, Huang, M L, Leu, C Y, Chiang, M S, Wu, P C, Lai   +5 more
openaire   +2 more sources

An inactivated hepatitis A viral vaccine of cell culture origin

Journal of Medical Virology, 1986
AbstractHepatitis A virus (HAV) strain CR326, adapted to grow in LLC‐MK2 cells, was highly purified, inactivated with formalin, adsorbed to alum, and tested for capacity to induce antibody to HAV in both mice and marmosets. The minimum dose of HAV antigen necessary to produce antibody in 50% of mice was 10 ng.
P J, Provost, J V, Hughes, W J, Miller, P A, Giesa, F S, Banker, E A, Emini   +5 more
openaire   +2 more sources

WITHDRAWN: Viral Hepatitis: global goals for vaccination

Journal of Clinical Virology, 2009
This article has been withdrawn at the request of the author. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
openaire   +2 more sources

A Vaccine for Viral Hepatitis Type B Appears on the Horizon

New England Journal of Medicine, 1973
The continued support for over 30 years of research in viral hepatitis by the United States Army Medical Research and Development Command seems about to pay off.
openaire   +2 more sources

Viral Hepatitis and Diabetes: Clinical Implications of Diabetes Prevention Through Hepatitis Vaccination

Current Diabetes Reports, 2016
Viral hepatitis has been posited to play a role in the development of type 2 diabetes. Thus, prevention of viral hepatitis through vaccination has the potential to reduce the burden of type 2 diabetes. We have shown that successful hepatitis B vaccination reduces the risk of diabetes by 33 %.
Rudruidee, Karnchanasorn, Horng-Yih, Ou, James, Lin, Lee-Ming, Chuang, Ken C, Chiu   +4 more
openaire   +2 more sources

The worldwide impact of vaccination on the control and protection of viral hepatitis B

Digestive and Liver Disease, 2011
Viral hepatitis B is a leading cause of acute and chronic liver disease worldwide, including cirrhosis and hepatocellular carcinoma. Vaccination is the most effective measure for controlling and preventing hepatitis B and its severe long-term sequelae.
L. Romanò, S. Paladini, P. Van Damme, A.R. Zanetti   +3 more
openaire   +3 more sources

[Preventive vaccination for viral hepatitis].

Zeitschrift fur Gastroenterologie, 1997
Viral hepatitis A-E belong to the most important infectious diseases worldwide. Viral hepatitis is highly endemic in most developing countries in Africa, South East Asia, and southern America; however also in industrialized countries as Germany hepatitis A, B and C represent a thread which should not be underestimated.
openaire   +1 more source

Viral hepatitis: 2. Hepatitis B vaccines.

Dental update, 1987
link_to_subscribed_fulltext
openaire   +2 more sources